Lupin appoints Alok Sonig as CEO – US Generics and Global Head –Generics R&D & Biosimilars
He will also be responsible for Lupin’s global Biosimilars business
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 129
Browsing Category
Latest Updates
Sun Pharma bags receipt of European Commission approval
The drug ILUMETRI (tildrakizumab) is indicated for the treatment of adults with moderate-to-severe chronic plaque psoriasis
Sun…
Alembic Pharma gets USFDA nod for depressive disorder drug
The company has received approval from the USFDA to market its product which is a generic equivalent of Wyeth Pharma Inc's Pristiq…
Aurobindo Pharma gets nod from South African health authority for HIV drug
The approval further strengthens the company's HIV product basket in South Africa, which has the potential to improve the lives of…
Romaco Pharmatechnik appoints Markus Regner as new MD
Markus Regner takes over at the Karlsruhe facility in Germany
SC allows sale of Saridon, three other drugs
The top court, however, did not grant any relief to the other medicines falling in the list of 328 FDC drugs which were banned by…
DoP urges pharma industry to develop innovative drugs
Pharmexcil organises seminar on Financial Schemes for Pharma industry and Outstanding Export Performance Awards at its 14 th…
Lupin appoints Dr Kamal K Sharma as Advisor
Dr Sharma has vast industry experience spanning over four decades
Lupin announced the appointment of Dr Kamal K Sharma as Advisor…
Alembic Pharma gets US FDA nod for diabetes drug
The company's product is a generic version of Takeda Pharma USA's Kazano tablets
Glenmark Pharma gets final US FDA nod for menopause symptom relief drug
The approved product is a generic version of Novo Nordisk's VAGIFEM